Core Insights - The company, Shandong Lanshun Biotechnology Co., Ltd., has rapidly established itself in the pet health supplement industry, achieving significant sales growth by addressing key health issues in pets [1][2]. Group 1: Company Development - The company was established in July 2024 and began production in October 2024, achieving a production value of 15 million in 2025, which is three times higher than the previous year [2]. - The company has successfully completed international quality management and food safety certifications within a short timeframe, enabling it to enter overseas markets [2]. Group 2: Product Offerings - The company specializes in a wide range of pet nutritional products, including powders, tablets, capsules, pastes, and drops, and has developed over a thousand products for various well-known brands [4]. - The flagship product line focuses on urinary health, specifically targeting urinary stones, with a reported effectiveness rate of 100% within seven days of use [5][7]. Group 3: Research and Development - The company integrates modern nutrition science with traditional Chinese medicine, utilizing effective plant extracts such as cranberry and plantain to enhance product efficacy [7]. - To improve palatability, the company has developed flavoring agents to mask unpleasant tastes, ensuring pets are willing to consume the supplements [7]. Group 4: Market Trends - The company is strategically expanding into the niche market of exotic pets, which has seen a rise in popularity, and is developing a full range of nutritional supplements tailored to the unique needs of these animals [8][9]. - The company anticipates significant growth in the parrot market, focusing on addressing behavioral health issues like feather pecking, with expected annual sales growth rates exceeding 50% [9]. Group 5: Future Directions - The company plans to continue focusing on clearly defined, functional products, with future research directed towards urinary health and the emerging parrot market [11].